![](/sites/default/files/styles/image_slider_1920x380/public/Events/Banner/banner-absreacr-microZAMOD-tanakawho.png?itok=LnO96EOu)
Background Note
Making a COVID-19 vaccine globally available once developedDevelopment and production of a COVID-19 vaccine There is a high risk that the intellectual property (IP) rights of a COVID-19 vaccine will effectively block people in many poorer countries from accessing it. To avoid this situation, I propose that a...